<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92464">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01976754</url>
  </required_header>
  <id_info>
    <org_study_id>FirstzhejiangU</org_study_id>
    <nct_id>NCT01976754</nct_id>
  </id_info>
  <brief_title>Safety Study of Dexmedetomidine in Septic Patients</brief_title>
  <official_title>The Effective Dose of Dexmedetomidine for Moderate Sedation of Adult Intubated Septic Patients in the ICU.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Zhejiang University</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Septic patients in Intensive Care Unit always need mechanical ventilation and
      conscious-sedation. But the recommended dose 0.2-0.7μg/kg/h could not run well because of
      wide range. The purpose of this study is to find the effective dose of dexmedetomidine adult
      septic patients of mechanical ventilation .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria:

      Age: between 18 years mechanical ventilation RASS≥2 A diagnosis of sepsis within 48 hours

      Exclusion Criteria:

      Cardiac disease Cardiac rhythm abnormalities liver dysfunction coma severe hypotension
      muscle relaxant users

      Primary Outcome Measures:

      Dose of dexmedetomidine

      Secondary Outcome Measures:

      RASS score Requirement for rescue intervention, RASS will be recorded  per hour.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Dose of dexmedetomidine</measure>
    <time_frame>12 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>RASS score Requirement for rescue intervention, RASS will be recorded per hour.</measure>
    <time_frame>1 hour</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Sepsis</condition>
  <condition>Agitation</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine,sepsis,ED50</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intervention Name: dexmedetomidine dosage form: intravenous injection dosage：0.2-0.7μg/kg/h frequency: 1 duration:12 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Septic patients are randomly received 1 of 6 doses( 0.2,0.3,0.4,0.5,0.6,0.7μg/kg/h) dexmedetomidine.</description>
    <arm_group_label>dexmedetomidine,sepsis,ED50</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  intubated patients RASS≥2 A diagnosis of sepsis within 48h

        Exclusion Criteria:

          -  Cardiac disease Cardiac rhythm abnormalities liver dysfunction coma severe
             hypotension muscle relaxant users
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xiangming fang, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>zhanqin zhang, PHD</last_name>
    <phone>0086-18758191189</phone>
    <email>zhangzhanqin12@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhanqin Zhang</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>zhanqin zhang, PHD</last_name>
      <phone>0086-18758191189</phone>
      <email>zhangzhanqin12@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 30, 2013</lastchanged_date>
  <firstreceived_date>October 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Zhejiang University</investigator_affiliation>
    <investigator_full_name>zhanqin zhang</investigator_full_name>
    <investigator_title>PHD candidate</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
